Oncologist and Patient Preferences for Attributes of CDK4/6 Inhibitor Regimens for the Treatment of Advanced/Metastatic HR Positive/HER2 Negative Breast Cancer: Discrete Choice Exp...

por Maculaitis, Martine C, Liu, Xianchen, Will, Oliver, Hanson, Madelyn, McRoy, Lynn, Berk, Alexandra, Crastnopol, Melissa
Publicado 2020